{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:16:23Z","timestamp":1791994583766,"version":"4.4.0"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,28]]},"abstract":"<jats:p>Our case demonstrates significant improvement in autoantibody levels and clinical outcomes, suggesting that telitacicept could be an alternative treatment for patients with mild pemphigus [Pemphigus Disease Area Index (PDAI) \uff1e9] who are not recommended for treatment with rituximab (PDAI \uff1c15), and especially for those unresponsive to conventional treatments or with treatment-resistant scalp lesions in pemphigus.<\/jats:p>","DOI":"10.1093\/bjd\/ljaf023","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T08:37:44Z","timestamp":1737103064000},"page":"955-957","source":"Crossref","is-referenced-by-count":5,"title":["Exploring telitacicept in a patient with pemphigus vulgaris"],"prefix":"10.1093","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3796-0395","authenticated-orcid":false,"given":"Quanhong","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Dermatology, Traditional Chinese and Western Medicine Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology , Wuhan ,","place":["China"]},{"name":"Department of Dermatology, Wuhan No. 1 Hospital , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Traditional Chinese and Western Medicine Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology , Wuhan ,","place":["China"]},{"name":"Department of Dermatology, Wuhan No. 1 Hospital , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bintao","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Wuhan No. 1 Hospital , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruili","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Traditional Chinese and Western Medicine Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology , Wuhan ,","place":["China"]},{"name":"Department of Dermatology, Wuhan No. 1 Hospital , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Yu","sequence":"additional","affiliation":[{"name":"Jianghan University School of Medicine , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuqing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Traditional Chinese and Western Medicine Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology , Wuhan ,","place":["China"]},{"name":"Department of Dermatology, Wuhan No. 1 Hospital , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9665-8506","authenticated-orcid":false,"given":"Jinbo","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Traditional Chinese and Western Medicine Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology , Wuhan ,","place":["China"]},{"name":"Department of Dermatology, Wuhan No. 1 Hospital , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"2025042813573253400_ljaf023-B1","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(19)31778-7","article-title":"Pemphigus","volume":"394","author":"Schmidt","year":"2019","journal-title":"Lancet"},{"key":"2025042813573253400_ljaf023-B2","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/jdv.16752","article-title":"Updated S2 K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the European Academy of Dermatology and Venereology (EADV)","volume":"34","author":"Joly","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025042813573253400_ljaf023-B3","doi-asserted-by":"crossref","first-page":"103291","DOI":"10.1016\/j.jaut.2024.103291","article-title":"Telitacicept: a novel horizon in targeting autoimmunity and rheumatic diseases","volume":"148","author":"Zeng","year":"2024","journal-title":"J Autoimmun"},{"key":"2025042813573253400_ljaf023-B4","doi-asserted-by":"crossref","first-page":"1298650","DOI":"10.3389\/fimmu.2023.1298650","article-title":"Combination treatment with telitacicept, cyclophosphamide and glucocorticoids for severe granulomatous polyangiitis: a case report and literature review","volume":"14","author":"Huang","year":"2023","journal-title":"Front Immunol"},{"key":"2025042813573253400_ljaf023-B5","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/jid.2010.91","article-title":"Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial","volume":"130","author":"Beissert","year":"2010","journal-title":"J Invest Dermatol"},{"key":"2025042813573253400_ljaf023-B6","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/1346-8138.12649","article-title":"Grading criteria for disease severity by pemphigus disease area index","volume":"41","author":"Shimizu","year":"2014","journal-title":"J Dermatol"},{"key":"2025042813573253400_ljaf023-B7","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa2028564","article-title":"Rituximab versus mycophenolate mofetil in patients with pemphigus vulgaris","volume":"384","author":"Werth","year":"2021","journal-title":"N Engl J Med"},{"key":"2025042813573253400_ljaf023-B8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12016-021-08882-1","article-title":"Comparison of guidelines for management of pemphigus: a review of systemic corticosteroids, rituximab, and other immunosuppressive therapies","volume":"61","author":"Zhao","year":"2021","journal-title":"Clin Rev Allergy Immunol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljaf023\/61476887\/ljaf023.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/192\/5\/955\/61476887\/ljaf023.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/192\/5\/955\/61476887\/ljaf023.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T17:57:41Z","timestamp":1745863061000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/192\/5\/955\/7959267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":8,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,1,17]]},"published-print":{"date-parts":[[2025,4,28]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljaf023","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,1,17]]}}}